GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » Beneish M-Score

Paul Hartmann AG (FRA:PHH2) Beneish M-Score : -2.88 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.88 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Paul Hartmann AG's Beneish M-Score or its related term are showing as below:

FRA:PHH2' s Beneish M-Score Range Over the Past 10 Years
Min: -3.08   Med: -2.72   Max: -2.45
Current: -2.88

During the past 13 years, the highest Beneish M-Score of Paul Hartmann AG was -2.45. The lowest was -3.08. And the median was -2.72.


Paul Hartmann AG Beneish M-Score Historical Data

The historical data trend for Paul Hartmann AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG Beneish M-Score Chart

Paul Hartmann AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.86 -3.08 -2.45 -2.48 -2.88

Paul Hartmann AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.45 - -2.48 - -2.88

Competitive Comparison of Paul Hartmann AG's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paul Hartmann AG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's Beneish M-Score falls into.



Paul Hartmann AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Paul Hartmann AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.999+0.528 * 1.0118+0.404 * 1.0871+0.892 * 1.018+0.115 * 1.0251
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9308+4.679 * -0.101854-0.327 * 0.9893
=-2.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €401 Mil.
Revenue was €2,353 Mil.
Gross Profit was €1,318 Mil.
Total Current Assets was €1,038 Mil.
Total Assets was €1,987 Mil.
Property, Plant and Equipment(Net PPE) was €654 Mil.
Depreciation, Depletion and Amortization(DDA) was €103 Mil.
Selling, General, & Admin. Expense(SGA) was €267 Mil.
Total Current Liabilities was €490 Mil.
Long-Term Debt & Capital Lease Obligation was €204 Mil.
Net Income was €28 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €231 Mil.
Total Receivables was €394 Mil.
Revenue was €2,312 Mil.
Gross Profit was €1,310 Mil.
Total Current Assets was €1,106 Mil.
Total Assets was €2,006 Mil.
Property, Plant and Equipment(Net PPE) was €627 Mil.
Depreciation, Depletion and Amortization(DDA) was €102 Mil.
Selling, General, & Admin. Expense(SGA) was €282 Mil.
Total Current Liabilities was €503 Mil.
Long-Term Debt & Capital Lease Obligation was €206 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(401.036 / 2353.262) / (394.347 / 2311.605)
=0.170417 / 0.170594
=0.999

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1309.964 / 2311.605) / (1318.067 / 2353.262)
=0.56669 / 0.560102
=1.0118

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1037.995 + 653.823) / 1986.787) / (1 - (1105.662 + 626.789) / 2006.477)
=0.148465 / 0.136571
=1.0871

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2353.262 / 2311.605
=1.018

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(101.65 / (101.65 + 626.789)) / (103.034 / (103.034 + 653.823))
=0.139545 / 0.136134
=1.0251

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(266.869 / 2353.262) / (281.638 / 2311.605)
=0.113404 / 0.121837
=0.9308

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((203.96 + 489.722) / 1986.787) / ((205.584 + 502.52) / 2006.477)
=0.349148 / 0.352909
=0.9893

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(28.422 - 0 - 230.785) / 1986.787
=-0.101854

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Paul Hartmann AG has a M-score of -2.88 suggests that the company is unlikely to be a manipulator.


Paul Hartmann AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Paul Hartmann AG (FRA:PHH2) Business Description

Traded in Other Exchanges
Address
Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Executives
Eduard Schleicher Supervisory Board
Britta Fünfstück Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines